Curis/$CRIS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Curis
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Ticker
$CRIS
Sector
Primary listing
Employees
34
Headquarters
Website
Curis Metrics
BasicAdvanced
$11M
-
-$0.58
-
-
Price and volume
Market cap
$11M
52-week high
$3.13
52-week low
$0.75
Average daily volume
169K
Financial strength
Current ratio
0.701
Quick ratio
0.393
Long term debt to equity
29.623
Total debt to equity
29.623
Profitability
EBITDA (TTM)
-5.536
Gross margin (TTM)
99.52%
Net profit margin (TTM)
-80.29%
Operating margin (TTM)
-60.50%
Revenue per employee (TTM)
$280,000
Management effectiveness
Return on assets (TTM)
-11.66%
Return on equity (TTM)
2,829.10%
Valuation
Price to revenue (TTM)
1.075
Price to book
2.22
Price to tangible book (TTM)
-3.45
Growth
Revenue change (TTM)
-13.43%
Earnings per share change (TTM)
-91.57%
3-year revenue growth (CAGR)
-2.42%
10-year revenue growth (CAGR)
1.83%
3-year earnings per share growth (CAGR)
-63.71%
10-year earnings per share growth (CAGR)
-35.67%
What the Analysts think about Curis
Analyst ratings (Buy, Hold, Sell) for Curis stock.
Curis Financial Performance
Revenues and expenses
Curis Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Curis stock?
Curis (CRIS) has a market cap of $11M as of March 21, 2026.
What is the P/E ratio for Curis stock?
The price to earnings (P/E) ratio for Curis (CRIS) stock is 0 as of March 21, 2026.
Does Curis stock pay dividends?
No, Curis (CRIS) stock does not pay dividends to its shareholders as of March 21, 2026.
When is the next Curis dividend payment date?
Curis (CRIS) stock does not pay dividends to its shareholders.
What is the beta indicator for Curis?
Curis (CRIS) does not currently have a Beta indicator.